Transcriptional profiling reveals a role for RORα in regulating gene expression in obesity-associated inflammation and hepatic steatosis

被引:77
|
作者
Kang, Hong Soon [1 ]
Okamoto, Kyoko [1 ]
Takeda, Yukimasa [1 ]
Beak, Ju Youn [1 ]
Gerrish, Kevin [2 ]
Bortner, Carl D. [3 ]
DeGraff, Laura M. [1 ]
Wada, Taira [4 ,5 ]
Xie, Wen [4 ,5 ]
Jetten, Anton M. [1 ]
机构
[1] NIEHS, Cell Biol Sect, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA
[2] NIEHS, Microarray Grp, NIH, Res Triangle Pk, NC 27709 USA
[3] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA
[4] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA
[5] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA
关键词
staggerer mice; obesity; metabolic syndrome; macrophage; insulin-resistance; diabetes; retinoid-related orphan receptors; ORPHAN NUCLEAR RECEPTOR; DIET-INDUCED OBESITY; INDUCED LUNG INFLAMMATION; ADIPOSE-TISSUE; DEFICIENT MICE; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; RETINOIC ACID; ADIPOCYTE DIFFERENTIATION; MACROPHAGE ACCUMULATION;
D O I
10.1152/physiolgenomics.00206.2010
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Retinoid-related orphan receptor (ROR)alpha 4 is the major ROR alpha isoform expressed in adipose tissues and liver. In this study we demonstrate that ROR alpha-deficient staggerer mice (ROR alpha(sg/sg)) fed with a high-fat diet (HFD) exhibited reduced adiposity and hepatic triglyceride levels compared with wild-type (WT) littermates and were resistant to the development of hepatic steatosis, adipose-associated inflammation, and insulin resistance. Gene expression profiling showed that many genes involved in triglyceride synthesis and storage, including Cidec, Cidea, and Mogat1, were expressed at much lower levels in liver of ROR alpha(sg/sg) mice. In contrast, overexpression of ROR alpha in mouse hepatoma Hepa1-6 cells significantly increased the expression of genes that were repressed in ROR alpha(sg/sg) liver, including Sult1b1, Adfp, Cidea, and ApoA4. ChIP and promoter analysis suggested that several of these genes were regulated directly by ROR alpha. In addition to reduced lipid accumulation, inflammation was greatly diminished in white adipose tissue (WAT) of ROR alpha(sg/sg) mice fed with an HFD. The infiltration of macrophages and the expression of many immune response and proinflammatory genes, including those encoding various chemo/cytokines, Toll-like receptors, and TNF signaling proteins, were significantly reduced in ROR alpha(sg/sg) WAT. Moreover, ROR alpha(sg/sg) mice fed with an HFD were protected from the development of insulin resistance. ROR alpha(sg/sg) mice consumed more oxygen and produced more carbon dioxide, suggesting increased energy expenditure in this genotype. Our study indicates that ROR alpha plays a critical role in the regulation of several aspects of metabolic syndrome. Therefore, ROR alpha may provide a novel therapeutic target in the management of obesity and associated metabolic diseases.
引用
收藏
页码:818 / 828
页数:11
相关论文
共 50 条
  • [1] Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism
    Qiao, Xin
    Zhou, Zhuo-Chao
    Niu, Rui
    Su, Yu-Tong
    Sun, Yue
    Liu, Hong-Lei
    Teng, Jia-Lin
    Ye, Jun-Na
    Shi, Hui
    Yang, Cheng-De
    Cheng, Xiao-Bing
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [2] Osteopontin Is a Mediator of Obesity-Associated Hepatic Steatosis and Insulin Resistance
    Kiefer, Florian W.
    Zeyda, Maximilian
    Neschen, Susanne
    Gollinger, Karina
    Pfau, Birgit
    Neuhofer, Angelika
    Weichhart, Thomas
    Kenner, Lukas
    Stulnig, Thomas M.
    DIABETES, 2009, 58 : A437 - A437
  • [3] The obesity-associated Fto gene is a transcriptional coactivator
    Wu, Qiong
    Saunders, Rudel A.
    Szkudlarek-Mikho, Maria
    de la Serna, Ivana
    Chin, Khew-Voon
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 401 (03) : 390 - 395
  • [4] Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
    Deveaux, Vanessa
    Cadoudal, Thomas
    Ichigotani, Yasukatsu
    Teixeira-Clerc, Fatima
    Louvet, Alexandre
    Manin, Sylvie
    Tran-Van Nhieu, Jeanne
    Belot, Marie Pierre
    Zimmer, Andreas
    Even, Patrick
    Cani, Patrice D.
    Knauf, Claude
    Burcelin, Remy
    Bertola, Adeline
    Le Marchand-Brustel, Yannick
    Gual, Philippe
    Mallat, Ariane
    Lotersztajn, Sophie
    PLOS ONE, 2009, 4 (06):
  • [5] Gene expression profiling reveals a regulatory role for RORα and RORα in phase I and phase II metabolism
    Kang, Hong Soon
    Angers, Martin
    Beak, Ju Youn
    Wu, Xiying
    Gimble, Jeffrey M.
    Wada, Taira
    Xie, Wen
    Collins, Jennifer B.
    Grissom, Sherry F.
    Jetten, Anton M.
    PHYSIOLOGICAL GENOMICS, 2007, 31 (02) : 281 - 294
  • [6] Metabolomic Profiling Reveals Mitochondrial-Derived Lipid Biomarkers That Drive Obesity-Associated Inflammation
    Sampey, Brante P.
    Freemerman, Alex J.
    Zhang, Jimmy
    Kuan, Pei-Fen
    Galanko, Joseph A.
    O'Connell, Thomas M.
    Ilkayeva, Olga R.
    Muehlbauer, Michael J.
    Stevens, Robert D.
    Newgard, Christopher B.
    Brauer, Heather A.
    Troester, Melissa A.
    Makowski, Liza
    PLOS ONE, 2012, 7 (06):
  • [7] Osteopontin deficiency prevents obesity-associated hepatic steatosis and insulin resistance
    Kiefer, F. W.
    Zeyda, M.
    Neschen, S.
    Gollinger, K.
    Pfau, B.
    Neuhofer, A.
    Weichhart, T.
    Kenner, L.
    Stulnig, T. M.
    DIABETOLOGIA, 2009, 52 : S33 - S33
  • [8] Osteopontin: A mediator of Obesity-associated hepatic Steatosis and Insulin resistance.
    Kiefer, Florian
    Zeyda, Maximilian
    Neschen, Susanne
    Gollinger, Karina
    Pfau, Birgit
    Neuhofer, Angelika
    Weichhart, Thomas
    Kenner, Lukas
    Stulnig, Thomas
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S17 - S17
  • [9] CB2 ANTAGONISM REDUCES INSULIN RESISTANCE AND HEPATIC STEATOSIS VIA A DECREASE IN OBESITY-ASSOCIATED INFLAMMATION
    Deveaux, Vanessa
    Ichigotani, Yasukatsu
    Codoudal, Thomas
    Teixeira-Clerc, Fatima
    Louvet, Alexandre
    Manin, Sylvie
    Van Nhieu, Jeanne Tran
    Belot, Morie-Pierre
    Zimmer, Andreas
    Bertola, Adeline
    Brustel, Yannick Le Marchand
    Gual, Philippe
    Mallat, Arione
    Lotersztajn, Sophie
    HEPATOLOGY, 2008, 48 (04) : 826A - 826A
  • [10] Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD
    Fernandez-Saez, Eva M.
    Losarcos, Maite
    Becerril, Sara
    Valenti, Victor
    Moncada, Rafael
    Martin, Marina
    Burrell, Maria A.
    Catalan, Victoria
    Gomez-Ambrosi, Javier
    Mugueta, Carmen
    Colina, Inmaculada
    Silva, Camilo
    Escadlada, Javier
    Fruhbeck, Gema
    Rodriguez, Amaia
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 147